Tags : Bioscience

M&A MedTech

Agilent to Acquire Resolution Bioscience for $695M

Shots: Resolution to receive $550M in cash at closing and ~$145M following the achievement of certain milestones. The transaction is expected to close in Apr’2021 The acquisition will expand Agilent’s capabilities in NGS-based cancer diagnostics and strengthen its position in precision oncology testing globally The acquisition will bring together Resolution’s noninvasive liquid biopsy platform that […]Read More